Organ-on-a-chip maker Emulate has launched an upgraded offering for researchers studying inflammatory bowel disease with its tissue model that helps illustrate how immune cells are activated and ...

The human guinea pig may soon be extinct. He (it’s usually a ‘he’) has become endangered through the advances of cell culture science, which increasingly close the gap between in vitro testing (the ...

Boston-based Emulate and the U.S. Food & Drug Administration’s Office of Foods and Veterinary Medicine have inked a Cooperative Research and Development Agreement (CRADA) to advance the company’s ...

Who will come up with the killer app for drug discovery, the thing that will make finding new medicines faster, cheaper, and less risky? No one has come close to figuring that out, but a group of ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc., today announced that Jim Corbett has been appointed as Chief Executive Officer and Martin Madaus, Ph.D., has been appointed Executive Chairman of the company’s ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc. announced today that it has formed a strategic partnership with F Hoffman La-Roche AG (Roche) that will use Emulate’s Human Emulation System across R&D programs ...

Small cellular models of human tissue can help researchers better understand how the body reacts under rare conditions. Now, Emulate’s organ-on-a-chip will help explore one of the rarest of all: how ...

Emulate has raised $82 million in a series E round to help further develop and commercialize its organ-on-a-chip technology. The Boston, MA company has raised a total of $225 million since it was ...

A Boston startup known for its plastic chips that simulate human organs announced the appointment of a new CEO on Thursday as it ramps up its commercial portfolio with new funding. Jim Corbett will ...

This article was first published in the May 2016 issue of WIRED magazine. Be the first to read WIRED's articles in print before they're posted online, and get your hands on loads of additional content ...